Tag Archives: biotechnology

Myriad Ruling: DNA Sequences Are Unpatentable “ Products Of Nature”

In a lengthy opinion released yesterday in Assoc. for Molec. Pathology v. USPTO, __F.Supp.2d___(S.D. N.Y.) (PDF below), the court invalidated claims directed to isolated DNA sequences, as well as to cancer screening methods using them, and even to methods of … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

Ariad v. Lilly Comes Down (On Us) – Judge Lourie Rules!

In a majority opinion authored by Judge Lourie for the Federal Circuit sitting en banc (Appeal No. 2008-1248 (Fed. Cir. March 22, 2010)) (a PDF of which is attached to the end of this post), the court held that there … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , | 1 Comment

PTO Launches Pilot Program to Speed Patenting Green Technologies

On December 8th, the Patent Office implemented a pilot program in which an applicant may have an unexamined application filed before December 8, 2009 made special upon a showing that the putative patent would “materially enhance the quality of the … Continue reading

Posted in USPTO Rules re 2AIA Patent Reform | Tagged , , , , | Leave a comment

Federal Circuit Reverses District Court's Finding that Generic Eloxatins do not Infringe Sanofi's Patent

In my June 22, 2009 post, I discussed the district court decision that found a claim to optically-pure oxaliplatin (U.S. Pat. No 5,338,874) not infringed by defendants who made it by processes other than the HPLC process disclosed in the … Continue reading

Posted in Prosecution History Estopped | Tagged , , , , , , , , , | Leave a comment